Zum Inhalt

Annals of Hematology

Ausgabe 12/2025

Inhalt (38 Artikel)

Richter’s transformation: status quo and quo vadis

  • Open Access
  • Review

Ibtesam M. Khalifa

Efficacy and safety of ropeginterferon alfa-2b in the treatment of polycythemia vera: a systematic review with single arm meta-analysis

  • Open Access
  • Review

Eman Ayman Nada, Mohamed Abdelhalim Elfagieh, Fares Abdelsalam, Asmaa Ahmed Elrashedy, Fatima A. Idres, Abdelrahman shata, Ali M. Othman, Hasan Mohammad Masoum Hamoud, Radwa Mohamed Awadalla, Israa Ahmed Qutob, Belal Mohamed Hamed

A direct multiplex isothermal amplification-reverse dot blot hybridization system for β-thalassemia diagnosis

  • Open Access
  • Research

Chao Ye, Xiaoxing Zhou, Yan Wei, Yilian Zhao, Mengru Xie, Xinchu Liu, Jinghui Ma, Jilin Qing, Zhizhong Chen

Can platelet to neutrophil ratio (PNR) serve as a viable alternative tool for monitoring sickle cell disease patients on hydroxyurea in low income countries?

  • Open Access
  • Research

Efobi Chilota Chibuife, Nri-Ezedi Chisom Adaobi, Franklin Odini, Habib Darbari Deepika, Nana-Bilkisu Habib, Campbell Andrew

Importance of the 3′UTR region in globin synthesis: identification of two novel HBA1 mutations causing α-Thalassemia

  • Open Access
  • Research

Sara Ferrer Benito, Mariola Abío, Eduardo J. Bardón-Cancho, Jorge M. Nieto, Belén Ortega, F. A. González, Ana Villegas, Celina Benavente, Paloma Ropero

The effects of adding decitabine to conditioning regimen for patients with acute myeloid leukemia or myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis

  • Open Access
  • Research

Chengxin Luo, Jianmin Zhang, Xiangtao Huang, Guixian Wu, Yarui Huang, Yaqun Ding, Zhen Huang, Qiuyue Song, Jieping Chen, Xi Li, Shuangnian Xu

Quantitative assessment of innate myeloid cells in myelofibrosis: insights into myeloid and plasmacytoid dendritic cell depletion and disease progression

  • Open Access
  • Research

Nathália Aparecida Cavalcante Silva, Fábio Pinotti Guirao, Míriam Cristina Rodrigues Barbosa, Diego Alonso Olavarría Bernal, Laura Coutinho Vassalli, Alex Freire Sandes

MiR-503-5p as a potential biomarker for deep venous thrombosis (DVT) in multiple myeloma (MM) and its role in disease development

  • Open Access
  • Research

Yifei Guo, Lixiang Yan, Xi Yang, Chenyang Fan, Reaila Jianati, Yanan Jia, Xiaogang Hao, Feng Ju, Zhexin Shi

The impact of CD81 on immune cells and clinical prognosis in multiple myeloma

  • Open Access
  • Research

Qian Zhao, Mengyao LV, Qing Yan, Yanfei Sun, Feng Li

Siltuximab monotherapy improves progression free survival compared to rituximab-based therapies in patients with idiopathic multicentric Castleman disease; indirect comparison of studies using single-arm metanalysis method and the generalized linear mixed model

  • Open Access
  • Research

Lazaros Karatisidis, Theodoros Mprotsis, Stergios Intzes, Konstantinos Zagoridis, Georgios Vrachiolias, Vera Karatisidou, Zoi Bezirgianidou, Konstantinos Liapis, Ioannis Kotsianidis, Emmanouil Spanoudakis

Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and Outcomes

  • Open Access
  • Research

Eva Erzar, Vanesa Sindi-Ivanova, Stefan Dirnhofer, Lučka Boltežar, Janja Ocvirk, Veronika Kloboves Prevodnik, Alexandar Tzankov, Gorana Gašljević

Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study

  • Open Access
  • Research

Jin-Ni Wang, Jie Xiong, Han-Guo Guo, Zhi-Hua Li, Yi Cao, Yu Fang, Yu-Ying Liu, Yan-Hong Li, Jun Cai, Yu-Chen Zhang, Qi-Hua Zou, Jia-Hui Wang, Yi Xia, Hui-Qiang Huang, Chang-Gang Sun, Song-Qi Li, Liang Wang, Wei-Li Zhao, Qing-Qing Cai

Outcomes in patients with relapsed/refractory multiple myeloma with extramedullary disease: a meta-analysis

  • Open Access
  • Research

Peter M. Voorhees, Shaji Kumar, Saad Z. Usmani, Jing Christine Ye, Yael C. Cohen, Emma Scott, Robin L. Carson, Christoph Heuck, Ryan Gan, Benjamin Ackerman, Jenny Zhang, Eleanor Caplan, Trilok Parekh, María-Victoria Mateos

Epstein-barr virus-encoded small RNA incorporated prognostic model enables precision risk stratification and guides treatment decisions in peripheral t-cell lymphoma: a multicenter retrospective cohort

  • Open Access
  • Research

Ze-Tao Chen, Ling Huang, Han-Guo Guo, Cai-Di Lin, Xin-Miao Jiang, Xiao-Juan Wei, Fei-Li Chen, Si-Chu Liu, Hong Zhang, Zhan-Li Liang, Ning Wang, Xiao-Dan Zhang, Li-E. LIN, Ting-Bo Liu, Ji-Hao Zhou, Zhi-Gang Peng, Wen-Yu Li

Paediatric lymphoblastic lymphoma: a national review of 20 years of clinical and biological data in Ireland

  • Open Access
  • Research

Amélie Trinquand, David R. Betts, Sean Rooney, Lorna Storey, Peter McCarthy, Neil Barrett, Jonathan Bond, Aengus O’Marcaigh, Andrea Malone, Owen P. Smith

Long term outcomes of older patients with classical hodgkin lymphoma: an analysis of the Texas cancer registry

  • Open Access
  • Research

Ethan A. Burns, Hala Hassanain, Sunil Mathur, Darshil Choksi, Yuqi Zhang, Cesar Gentille Sanchez, Chih-hang Anthony Tang, Hanh Mai, Carrie Yuen, Shilpan Shah, Siddhartha Ganguly, Chih-chi Andrew Hu, Sai Ravi Pingali

Development of an artificial intelligence-based early diagnostic system for light-chain amyloidosis

  • Open Access
  • Research

Wei Yan, Jian Chen, Tao He, Haoze Xu, Jianmin Chen, Xiaoyu Liu, Liye Zhong, Yan Li, Chunyan Sun, Xiaobo Wang, Li Gao, Fengyan Jin, Bingzong Li, Chunrui Li, Yingyou Wen, Zhuo Chen, Boheng Liu, Jian Li, Huihan Wang

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients

  • Open Access
  • Research

Loïc Osanno, Lucy Brocque, Laurent Bourguignon, Carla Delpech, Laure Farnault, Julien Colle, Pauline Roche, Jacques Chiaroni, Caroline Izard, Régis Costello, Mathilde Dacos, Caroline Solas, Chems Djezzar, Joseph Ciccolini, Thomas Cluzeau, Geoffroy Venton, Raphaëlle Fanciullino

Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia

  • Open Access
  • Research

Junjie Chen, Jia Li, Zhixiang Wang, Zicong Huang, Jieping Lin, Jiawang Ou, Xiuli Xu, Bingqing Tang, Chenhao Ding, Zihong Cai, Ren Lin, Xuan Li, Qifa Liu, Hongsheng Zhou

Real-world clinical outcomes of CAR-T therapy from the Montefiore health system in the Bronx

  • Open Access
  • Research

Sonya Henry, Ahmed Abbasi, Aiman Hafeez, Aditi Vichare, R. Alejandro Sica, Tim Q. Duong

Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study

  • Open Access
  • Research

Yuqing Tu, Lingyi Yang, Yaxin Cheng, Yanming Zhang, Yinghao Lu, Shushu Xu, Xiaoli Li, Mimi Xu, Mengqi Xiang, Yi Fan, Yuhua Ru, Yang Xu, Feng Chen, Xiaojin Wu, Yulian Zheng, Fei Li, Yue Han, Xiaowen Tang, Huiying Qiu, Miao Miao, Ye Zhao, Xiaoyu Zhu, Depei Wu, Jia Chen

Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric study

  • Open Access
  • Brief Report

Raphaël Maguet, Martin Eloit, Olivier Chinot, Pierre Soubeyran, Carole Soussain, Roch Houot, Guido Ahle, Vincent Delwail, Aline Clavert, Lucie Oberic, Renata Ursu, Hélène Sellenart, Julie Abraham, Olivier Herault, Caroline Houillier, Emmanuel Gyan

Olverembatinib for 8p11 myeloproliferative syndrome with a positive BCR-FGFR1 fusion gene: a case report

  • Open Access
  • Case Report

Man Wu, Lin Huang, Yibin Yao, Yuling Xu, Yang Yang, Jun Luo, Zhenfang Liu

Hemophagocytic lymphohistiocytosis caused by dual mutations in UNC13D and STX11 induced by HHV-7: a case report and review of the literature

  • Open Access
  • Case Report

Xiaoqiong Wang, Yao Zhang, Lijuan Zhou, Xiaona Yin, Chuchu Xu, Jiakui Zhang, Fangbin Du, Yongsheng Wang

The first Chinese hb m-saskatoon [HBB: c.190 c > t p.His64Tyr] case with low oxygen saturation in 50-year-old women

  • Open Access
  • Case Report

Yingjun Zhang, Ge Zhang, Lei Ye, Qingkai Dai, Luyun Peng, Rui Shi, Siqi Guo, Jiajing He, Hao Yang, Wenling Shang, Ke Huang, Liang Zhang, Yuefang Wang

Bilateral facial palsy as presenting symptom of post-transplant relapsed acute myeloid leukemia treated with venetoclax: a case report and literature review

  • Open Access
  • Case Report

Cecilia Diamanti, Vincenzo Apolito, Manuela Spadea, Valeria Ceolin, Anna Mussano, Alessio Tomatis, Marta Barone, Paola Quarello, Francesco Saglio, Franca Fagioli

Efficacy of PR2-based immunotherapy in the treatment of diffuse large B-cell lymphoma-associated neurolymphomatosis: A report on two cases

  • Open Access
  • Case Report

Xiangmin Wang, Qing Zhang, Hongyuan Zhou, Weidong Li, Hui Liu, Xiumin Hou, Jie Zu, Wei Sang

Acquired Gray platelet syndrome as a rare hematologic complication in a case of JAK2-positive post polycythemia Vera myelofibrosis

  • Open Access
  • Case Report

Aishwarya Pradeep, Ayo S. Falade, Juliana Perez Botero, Dong C. Chen, Rajiv K. Pruthi, Aasiya Matin

Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis

  • Open Access
  • Case Report

Natasha Venugopal, Andrew McGowan, Yoshitaka Inoue, Hong Zheng, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Seema Naik, Christopher Ehmann, Jeffrey Sivik, Joseph Mierski, Brooke Silar, Caitlin Vajdic, Hiroko Shike, Shin Mineishi, Kentaro Minagawa

Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​

  • Open Access
  • Correspondence

Xiaoyu Zhang, Yanhong Zhao, Weihua Zhai, Qiaoling Ma, Yigeng Cao, Jialin Wei, Chen Liang, Xin Chen, Wenbin Cao, Donglin Yang, Aiming Pang, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Combination therapy based on venetoclax overcomes resistance to all-trans retinoic acid and arsenic trioxide in a variant acute promyelocytic leukemia with TNRC18::RARA fusion

  • Open Access
  • Correspondence

Wenjing Ding, Jun Zhao, Zheng Wang, Yongjing Liu, Man Wang, Hongjie Shen, Yun Chen, Jinyan Huang, Dong Li, Suning Chen, Lijun Wen

Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy

  • Open Access
  • Correction

Concetta Conticello, Vittorio Del Fabro, Alessandra Romano, Anna Mele, Roberto Mina, Sara Bringhen, Alessandra Orofino, Elisabetta Antonioli, Stefano Pulini, Lorenzo De Paoli, Tommaso Za, Emilia Cotzia, Federica Elia, Andrea Casson, Eleonora Prete, Stefania Citiso, Carmine Liberatore, Gloria Margiotta-Casaluci, Francesca Fazio, Sonia Morè, Irene Attucci, Fabrizio Accardi, Velia Bongarzoni, Silvia Mangiacavalli, Elena Rossi, Donato Mannina, Bruno Garibaldi, Rita Rizzi, Monica Di Cecca, Bernardino Rossini, Giuseppina Uccello, Cirino Botta, Dario Leotta, Donatella Vincelli, Massimo Gentile, Alfonso Piciocchi, Giovanni Marsili, Francesca Patriarca, Renato Zambello, Pellegrino Musto, Mario Boccadoro, Massimo Offidani, Maria Teresa Petrucci, Francesco Di Raimondo

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Fokale Salvage-Therapie bei lokalem Prostatakrebsrezidiv langfristig wirksam

Bei einem nach Radiotherapie lokal rezidivierten Prostatakarzinom sind fokale Salvage-Therapien mit einer guten Prognose verbunden: Das krebsspezifische Zehn-Jahres-Überleben ist einem retrospektiven Vergleich zufolge ebenso hoch wie nach Salvage-Prostatektomie.

Relacorilant verlängert Überleben bei platinresistentem Ovarialkarzinom

Durch Hinzunahme des Glukokortikoid-Rezeptor-Antagonisten Relacorilant zu nab-Paclitaxel wird bei Frauen mit platinresistentem Ovarialkarzinom nicht nur das progressionsfreie, sondern auch das Gesamtüberleben verlängert. Laut finaler Analyse der ROSELLA-Studie gewinnen sie vier Monate an Lebenszeit.

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Extrapulmonale Befunde beim Lungenkrebs-Screening – Krebsverdacht gerechtfertigt?

Der Umgang mit Zufallsentdeckungen ist ein vieldiskutiertes Thema im Zusammenhang mit dem Low-Dose-CT-Screening auf Lungenkrebs. Eine Studie hat sich nun speziell mit inzidentellen Befunden befasst, die auf ein extrapulmonales Malignom verdächtig sind.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell), Mann erhält einen CT-Scan /© Mark Kostich / stock.adobe.com (Symbolbild mit Fotomodell)